Oneness Biotech Co., Ltd.(TW:4743)
NT$47.10+0.60 (+4.78%)
TW:4743
Oneness Biotech Co., Ltd. financials statements
NT$47.10
At close:+0.60 (+4.78%)
Oneness Biotech Co., Ltd. (4743) Financial Statements
Oneness Biotech Co., Ltd. Financial Overview
Oneness Biotech Co., Ltd.'s market cap is currently NT$22.59B. The company's EPS TTM is NT$0.13; its P/E ratio is -101.39; and it has a dividend yield of 0.05%. Oneness Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 129.12M | NT$ 117.93M | NT$ 86.78M | NT$ 1.07B | NT$ 65.77M |
| Gross Profit | NT$ 35.95M | NT$ 63.03M | NT$ 32.56M | NT$ 844.39M | NT$ 45.04M |
| Operating Income | NT$ -803.01M | NT$ -1.09B | NT$ -1.10B | NT$ 456.22M | NT$ -391.06M |
| EBITDA | NT$ -469.09M | NT$ -685.71M | NT$ -647.63M | NT$ 253.19M | NT$ -193.72M |
| Net Income | NT$ -1.04B | NT$ -1.17B | NT$ -1.31B | NT$ 359.98M | NT$ -412.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 5.82B | NT$ 7.02B | NT$ 7.77B | NT$ 8.05B | NT$ 7.81B |
| Total Assets | NT$ 11.73B | NT$ 13.66B | NT$ 15.36B | NT$ 15.58B | NT$ 15.73B |
| Total Debt | NT$ 370.73M | NT$ 406.35M | NT$ 432.20M | NT$ 263.45M | NT$ 283.82M |
| Net Debt | NT$ -1.29B | NT$ -641.40M | NT$ -380.63M | NT$ -5.39B | NT$ -49.13M |
| Total Liabilities | NT$ 1.26B | NT$ 859.65M | NT$ 866.43M | NT$ 700.38M | NT$ 1.64B |
| Stockholders' Equity | NT$ 10.33B | NT$ 12.30B | NT$ 14.05B | NT$ 14.62B | NT$ 14.02B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -470.89M | NT$ -398.86M | NT$ -512.23M | NT$ -970.19M | NT$ -389.19M |
| Operating Cash Flow | NT$ -448.93M | NT$ -345.58M | NT$ -422.18M | NT$ -881.00M | NT$ -288.89M |
| Investing Cash Flow | NT$ 1.07B | NT$ 544.16M | NT$ -4.82B | NT$ 5.74B | NT$ 59.54M |
| Financing Cash Flow | NT$ -12.49M | NT$ 19.70M | NT$ 386.58M | NT$ 451.87M | NT$ 344.67M |
Currency in TWD
